Information Provided By:
Fly News Breaks for September 15, 2016
ARNA
Sep 15, 2016 | 07:29 EDT
FBR Capital analyst Christopher James started Arena Pharmaceuticals with an Outperform rating and $6 price target.
News For ARNA From the Last 2 Days
There are no results for your query ARNA